newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

ZURICH, SWITZERLAND, July 29, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today provided an update on its core patent portfolio.